The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection.
about
The Surprising Role of Amyloid Fibrils in HIV InfectionAminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomeraseInnate defences against viraemia.The "CPC clip motif": a conserved structural signature for heparin-binding proteins.Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virusHeparin-protein interactions.Mosquito heparan sulfate and its potential role in malaria infection and transmission.The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.Heparin: an intervenor in cell communication.Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.
P2860
Q33570363-E52AB782-C7C0-4BF2-A539-4AD8F3196D80Q33581944-B5F81948-97ED-414D-87F9-4EAA7B174A4AQ33810106-EBAB3565-8A16-4404-ABE7-39A45AF133F3Q34103163-8C4CD121-AD55-41AB-B2F4-153EBF9CAF6CQ34374614-6CC09F42-272B-4F69-B876-4D12E2CC998EQ34734101-EF5939EA-1A9B-4E43-966E-ED28F5C5FCABQ35030190-74A79456-8215-4255-A51F-7F077EE06022Q36238824-E035B593-3731-4BD6-8E78-2C31E3768942Q37033246-62EA8994-DEFE-4F71-9B9B-21999564A6E9Q37334941-E61CC056-8720-4BAB-B3C6-5B233ECCEFC8Q41039144-7F6071C3-C626-4D69-9DCC-1A5F9AFBEB49
P2860
The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The potential for heparin and ...... prevention of HIV-1 infection.
@en
type
label
The potential for heparin and ...... prevention of HIV-1 infection.
@en
prefLabel
The potential for heparin and ...... prevention of HIV-1 infection.
@en
P356
P1476
The potential for heparin and ...... prevention of HIV-1 infection.
@en
P2093
P2888
P304
P356
10.1023/A:1018596728605
P577
1997-08-01T00:00:00Z
P6179
1005395834